BlackRock’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $61.1B | Sell |
66,380,842
-412,021
| -0.6% | -$418M | 1.07% | 11 |
|
|
2025
Q4 | $71.8B | Buy |
66,792,863
+983,100
| +1% | +$940M | 1.21% | 10 |
|
|
2025
Q3 | $50.2B | Sell |
65,809,763
-151,898
| -0.2% | -$113M | 0.88% | 12 |
|
|
2025
Q2 | $51.4B | Buy |
65,961,661
+269,688
| +0.4% | +$210M | 0.98% | 12 |
|
|
2025
Q1 | $54.3B | Buy |
65,691,973
+462,859
| +0.7% | +$385M | 1.14% | 10 |
|
|
2024
Q4 | $50.4B | Buy |
65,229,114
+887,985
| +1% | +$735M | 1.02% | 10 |
|
|
2024
Q3 | $57B | Sell |
64,341,129
-1,515,066
| -2% | -$1.36B | 1.2% | 9 |
|
|
2024
Q2 | $59.6B | Buy |
65,856,195
+581,810
| +0.9% | +$465M | 1.35% | 8 |
|
|
2024
Q1 | $50.8B | Buy |
65,274,385
+907,952
| +1% | +$646M | 1.18% | 8 |
|
|
2023
Q4 | $37.5B | Sell |
64,366,433
-1,307,501
| -2% | -$763M | 0.96% | 12 |
|
|
2023
Q3 | $35.3B | Buy |
65,673,934
+1,222,210
| +2% | +$630M | 1.01% | 11 |
|
|
2023
Q2 | $30.2B | Sell |
64,451,724
-1,119,801
| -2% | -$470M | 0.83% | 12 |
|
|
2023
Q1 | $22.5B | Buy |
65,571,525
+490,044
| +0.8% | +$165M | 0.66% | 19 |
|
|
2022
Q4 | $23.8B | Buy |
65,081,481
+1,740,348
| +3% | +$617M | 0.75% | 18 |
|
|
2022
Q3 | $20.5B | Sell |
63,341,133
-410,577
| -0.6% | -$130M | 0.7% | 15 |
|
|
2022
Q2 | $20.7B | Sell |
63,751,710
-244,609
| -0.4% | -$73.4M | 0.66% | 18 |
|
|
2022
Q1 | $18.3B | Buy |
63,996,319
+363,797
| +0.6% | +$93.6M | 0.49% | 24 |
|
|
2021
Q4 | $17.6B | Buy |
63,632,522
+3,676,934
| +6% | +$932M | 0.45% | 30 |
|
|
2021
Q3 | $13.9B | Sell |
59,955,588
-972,069
| -2% | -$240M | 0.39% | 41 |
|
|
2021
Q2 | $14B | Buy |
60,927,657
+1,856,395
| +3% | +$373M | 0.39% | 39 |
|
|
2021
Q1 | $11B | Buy |
59,071,262
+259,494
| +0.4% | +$50.8M | 0.32% | 53 |
|
|
2020
Q4 | $9.93B | Sell |
58,811,768
-1,659,871
| -3% | -$248M | 0.32% | 54 |
|
|
2020
Q3 | $8.95B | Sell |
60,471,639
-2,358,862
| -4% | -$365M | 0.33% | 54 |
|
|
2020
Q2 | $10.3B | Sell |
62,830,501
-1,468,976
| -2% | -$225M | 0.41% | 41 |
|
|
2020
Q1 | $8.92B | Buy |
64,299,477
+3,420,265
| +6% | +$470M | 0.44% | 42 |
|
|
2019
Q4 | $8B | Sell |
60,879,212
-267,796
| -0.4% | -$31M | 0.31% | 58 |
|
|
2019
Q3 | $6.84B | Sell |
61,147,008
-832,137
| -1% | -$92.6M | 0.29% | 61 |
|
|
2019
Q2 | $6.87B | Buy |
61,979,145
+898,845
| +1% | +$106M | 0.29% | 59 |
|
|
2019
Q1 | $7.93B | Sell |
61,080,300
-7,876,219
| -11% | -$958M | 0.35% | 46 |
|
|
2018
Q4 | $7.98B | Buy |
68,956,519
+2,030,845
| +3% | +$227M | 0.4% | 40 |
|
|
2018
Q3 | $7.18B | Buy |
66,925,674
+280,777
| +0.4% | +$28.1M | 0.31% | 56 |
|
|
2018
Q2 | $5.69B | Buy |
66,644,897
+864,451
| +1% | +$71M | 0.26% | 65 |
|
|
2018
Q1 | $5.09B | Buy |
65,780,446
+1,926,334
| +3% | +$155M | 0.24% | 69 |
|
|
2017
Q4 | $5.39B | Buy |
63,854,112
+776,893
| +1% | +$66.1M | 0.26% | 68 |
|
|
2017
Q3 | $5.4B | Sell |
63,077,219
-506,528
| -0.8% | -$41.5M | 0.27% | 64 |
|
|
2017
Q2 | $5.23B | Buy |
63,583,747
+1,323,259
| +2% | +$108M | 0.28% | 61 |
|
|
2017
Q1 | $5.24B | Buy |
62,260,488
+59,978,664
| +2,629% | +$4.8B | 0.29% | 55 |
|
|
2016
Q4 | $168M | Sell |
2,281,824
-311,447
| -12% | -$23.2M | 0.24% | 79 |
|
|
2016
Q3 | $208M | Sell |
2,593,271
-518,489
| -17% | -$41.5M | 0.3% | 63 |
|
|
2016
Q2 | $245M | Buy |
3,111,760
+471,063
| +18% | +$35.5M | 0.37% | 54 |
|
|
2016
Q1 | $190M | Sell |
2,640,697
-629,645
| -19% | -$47.6M | 0.31% | 66 |
|
|
2015
Q4 | $276M | Buy |
3,270,342
+512,706
| +19% | +$42.5M | 0.4% | 50 |
|
|
2015
Q3 | $231M | Buy |
2,757,636
+273,420
| +11% | +$23.1M | 0.36% | 58 |
|
|
2015
Q2 | $207M | Sell |
2,484,216
-232,285
| -9% | -$17.7M | 0.31% | 64 |
|
|
2015
Q1 | $197M | Buy |
2,716,501
+151,565
| +6% | +$10.8M | 0.27% | 76 |
|
|
2014
Q4 | $177M | Buy |
2,564,936
+45,008
| +2% | +$3.04M | 0.25% | 83 |
|
|
2014
Q3 | $163M | Sell |
2,519,928
-470,227
| -16% | -$29.8M | 0.24% | 93 |
|
|
2014
Q2 | $186M | Sell |
2,990,155
-574,848
| -16% | -$34.3M | 0.28% | 80 |
|
|
2014
Q1 | $210M | Sell |
3,565,003
-151,619
| -4% | -$8.46M | 0.34% | 61 |
|
|
2013
Q4 | $190M | Buy |
3,716,622
+237,932
| +7% | +$11.9M | 0.31% | 67 |
|
|
2013
Q3 | $175M | Buy |
3,478,690
+909,498
| +35% | +$47.6M | 0.33% | 64 |
|
|
2013
Q2 | $126M | Buy |
+2,569,192
| New | +$140M | 0.25% | 80 |
|
Other funds holding LLY
VCM
VPM
BlackRock's LLY Position: Q1 2026 in Review
BlackRock reduced its Eli Lilly (LLY) stake by 0.62% in Q1 2026, selling an estimated $418M and leaving 66,380,842 shares worth $61.1B. The position accounts for 1.07% of the portfolio, ranked #11.
BlackRock first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $71.8B in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- BlackRock held 66,380,842 shares of Eli Lilly worth $61.1B as of Q1 2026.
- BlackRock sold 412,021 Eli Lilly shares in Q1 2026, an estimated $418M.
- Eli Lilly made up 1.07% of BlackRock's portfolio in Q1 2026, its #11 holding.
- BlackRock first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- BlackRock's Eli Lilly position peaked at $71.8B in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.